{"metadata":{"generator":"Captivate","generatorVersion":"8.0.1","schemaVersion":"","author":"Professional Education ","title":"Reviewing prescriptions and protocols eQuiz","description":"project description","email":"eviqed@eviq.org.au","website":"www.cancerinstitute.org.au","tags":"","thumbnail":"","source":"assets","durationInFrames":1530,"frameRate":30,"totalSlides":13,"width":995,"height":627,"responsive":false,"scalable":false,"launchFile":"index_SCORM.html"},"contentStructure":[{"id":"si16853","class":"TODO::Senthil","roles":{}},{"id":"si17733","class":"TODO::Senthil","title":"Click to  Begin  ","roles":{"click":{"subtype":"button"},"textData":{}}},{"id":"si19508","class":"TODO::Senthil","roles":{}},{"id":"si19525","class":"TODO::Senthil","roles":{}},{"id":"SmartShape_135","class":"TODO::Senthil","instance":"SmartShape_135","title":"eQuiz   Reviewing prescriptions and protocols ","roles":{"click":{"subtype":"button"},"textData":{}}},{"id":"Button_84","class":"TODO::Senthil","instance":"Button_84","roles":{"click":{"subtype":"button"}}},{"id":"Text_Caption_601","class":"TODO::Senthil","instance":"Text_Caption_601","title":"Version 2.1 | August 2015 ","roles":{"textData":{}}},{"id":"Slide3935","class":"Normal Slide","instance":"Welcome","thumbnail":"","children":["si16853","si19508","si19525","Text_Caption_601"],"roles":{"slide":{"durationInFrames":90},"navigation":{"navid":"Slide3935"}}},{"id":"si43984","class":"TODO::Senthil","title":" ","roles":{"click":{"subtype":"button"},"textData":{}}},{"id":"si43993","class":"TODO::Senthil","title":" ","roles":{"click":{"subtype":"button"},"textData":{}}},{"id":"SmartShape_136","class":"TODO::Senthil","instance":"SmartShape_136","title":"Welcome to the eQuiz for    ","roles":{"click":{"subtype":"button"},"textData":{}}},{"id":"SmartShape_137","class":"TODO::Senthil","instance":"SmartShape_137","title":"Reviewing prescriptions and protocols  ","roles":{"click":{"subtype":"button"},"textData":{}}},{"id":"SmartShape_139","class":"TODO::Senthil","instance":"SmartShape_139","title":"Name: ","roles":{"click":{"subtype":"button"},"textData":{}}},{"id":"SmartShape_140","class":"TODO::Senthil","instance":"SmartShape_140","title":"Date: ","roles":{"click":{"subtype":"button"},"textData":{}}},{"id":"Text_Entry_Box_1","class":"TODO::Senthil","instance":"Text_Entry_Box_1","roles":{"textEntry":{"question":"","correctAnswers":{"caseMatters":false,"answers":[]},"constraints":{"length":-1}}}},{"id":"Text_Entry_Button_1","class":"TODO::Senthil","instance":"Text_Entry_Button_1","title":"Submit ","roles":{"click":{"subtype":"button"},"textData":{}}},{"id":"Text_Entry_Box_2","class":"TODO::Senthil","instance":"Text_Entry_Box_2","roles":{"textEntry":{"question":"","correctAnswers":{"caseMatters":false,"answers":[]},"constraints":{"length":-1}}}},{"id":"SmartShape_141","class":"TODO::Senthil","instance":"SmartShape_141","title":"Before attempting this eQuiz, it is strongly recommended you review the associated eLearning guide. The required pass mark for this eQuiz is 100%. If you do not achieve the required 100% pass mark you may attempt the eQuiz again. If you are unable to achieve the required pass mark after 3 attempts please speak to your local ADAC facilitator or a member of your education team.  To start please type your name and the date in the boxes below. These will be printed on your results page. ","roles":{"click":{"subtype":"button"},"textData":{}}},{"id":"Slide43532","class":"Normal Slide","instance":"","thumbnail":"","children":["Text_Entry_Box_1","Text_Entry_Button_1","Text_Entry_Box_2"],"roles":{"slide":{"durationInFrames":90},"navigation":{"navid":"Slide43532"}}},{"id":"Slide44027","class":"Random Question Slide","instance":"","thumbnail":"","roles":{"slide":{"durationInFrames":0},"navigation":{"navid":"Slide44027"}}},{"id":"Slide44048","class":"Random Question Slide","instance":"","thumbnail":"","roles":{"slide":{"durationInFrames":0},"navigation":{"navid":"Slide44048"}}},{"id":"Slide44069","class":"Random Question Slide","instance":"","thumbnail":"","roles":{"slide":{"durationInFrames":0},"navigation":{"navid":"Slide44069"}}},{"id":"si15354","class":"TODO::Senthil","roles":{}},{"id":"si17786","class":"TODO::Senthil","title":" ","roles":{"click":{"subtype":"button","question":"Slide44237q3"},"textData":{}}},{"id":"si18284","class":"TODO::Senthil","title":" ","roles":{"click":{"subtype":"button","question":"Slide44237q3"},"textData":{}}},{"id":"si44270","class":"TODO::Senthil","title":"Calculate the patient’s BSA using the Mosteller method of calculation.   Height is 182 cm. Weight is 80 kg. ","roles":{"textData":{}}},{"id":"si44285","class":"TODO::Senthil","title":"A) ","roles":{"textData":{}}},{"id":"si44289","class":"TODO::Senthil","title":"1.81 m2 ","roles":{"textData":{}}},{"id":"si44285_a","class":"TODO::Senthil","roles":{"answer":{"title":"1.81 m2\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si44296","class":"TODO::Senthil","title":"B) ","roles":{"textData":{}}},{"id":"si44300","class":"TODO::Senthil","title":"2.01 m2 ","roles":{"textData":{}}},{"id":"si44296_a","class":"TODO::Senthil","roles":{"answer":{"title":"2.01 m2\r","index":"Not implemented","score":{"weight":10}}}},{"id":"si44345","class":"TODO::Senthil","title":"C) ","roles":{"textData":{}}},{"id":"si44349","class":"TODO::Senthil","title":"1.53 m2 ","roles":{"textData":{}}},{"id":"si44345_a","class":"TODO::Senthil","roles":{"answer":{"title":"1.53 m2\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si44360","class":"TODO::Senthil","title":"D) ","roles":{"textData":{}}},{"id":"si44364","class":"TODO::Senthil","title":"1.90 m2 ","roles":{"textData":{}}},{"id":"si44360_a","class":"TODO::Senthil","roles":{"answer":{"title":"1.90 m2\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si44316","class":"TODO::Senthil","roles":{}},{"id":"si44324","class":"TODO::Senthil","title":"Submit ","roles":{"click":{"subtype":"submit","question":"Slide44237q3","for":"Slide44237q3"},"textData":{}}},{"id":"si44304","class":"TODO::Senthil","title":"Congratulations.   You selected the correct response.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si44308","class":"TODO::Senthil","title":"You did not select the correct response.  Please review the calculating BSA & antineoplastic drug doses section in the eLearning guide.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si44312","class":"TODO::Senthil","title":"You must answer the question before continuing. ","roles":{"textData":{}}},{"id":"Slide44237","class":"Question Slide","instance":"","thumbnail":"","children":["si15354","si44270","si44289","si44300","si44349","si44364","si44324","si44312"],"roles":{"slide":{"durationInFrames":90},"navigation":{"navid":"Slide44237"},"question":{"interactionId":"44250","quizId":455,"title":"Multiple Choice","text":"Calculate the patient’s BSA using the Mosteller method of calculation. \r\rHeight is 182 cm. Weight is 80 kg.\r","type":0,"interactionType":"choice","ramdomized":false,"correctAnswers":["B"],"score":{"weight":1,"penalty":0}}}},{"id":"Slide44111","class":"Random Question Slide","instance":"","thumbnail":"","roles":{"slide":{"durationInFrames":0},"navigation":{"navid":"Slide44111"}}},{"id":"Slide44132","class":"Random Question Slide","instance":"","thumbnail":"","roles":{"slide":{"durationInFrames":0},"navigation":{"navid":"Slide44132"}}},{"id":"Text_Caption_530","class":"TODO::Senthil","instance":"Text_Caption_530","title":"Link to ICE protocol  ","roles":{"textData":{}}},{"id":"Text_Caption_531","class":"TODO::Senthil","instance":"Text_Caption_531","title":"Link to prescription chart  ","roles":{"textData":{}}},{"id":"si44401","class":"TODO::Senthil","title":"Your patient’s height is 160cm, weight is 62.5kg. She is due to receive cycle 1 of ICE, for non-Hodgkin Lymphoma. First calculate her BSA using the eviQ calculator and then calculate the antineoplastic drug doses she is to receive.   Review the prescription chart to determine what is incorrect on the prescription chart. Note: More than one answer may be correct. ","roles":{"textData":{}}},{"id":"si44416","class":"TODO::Senthil","title":"A) ","roles":{"textData":{}}},{"id":"si44420","class":"TODO::Senthil","title":"The dose of ifosfamide is incorrect. ","roles":{"textData":{}}},{"id":"si44420","class":"TODO::Senthil","roles":{"click":{"subtype":"button","question":"Slide44368q6"},"answer":{"title":"dummy title","index":-1,"score":{}}}},{"id":"si44416_a","class":"TODO::Senthil","roles":{"answer":{"title":"The dose of ifosfamide is incorrect.\r","index":"Not implemented","score":{"weight":10}}}},{"id":"si44427","class":"TODO::Senthil","title":"B) ","roles":{"textData":{}}},{"id":"si44431","class":"TODO::Senthil","title":"The patient details. ","roles":{"textData":{}}},{"id":"si44431","class":"TODO::Senthil","roles":{"click":{"subtype":"button","question":"Slide44368q6"},"answer":{"title":"dummy title","index":-1,"score":{}}}},{"id":"si44427_a","class":"TODO::Senthil","roles":{"answer":{"title":"The patient details.\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si44678","class":"TODO::Senthil","title":"C) ","roles":{"textData":{}}},{"id":"si44682","class":"TODO::Senthil","title":"The carboplatin dose is not ordered. ","roles":{"textData":{}}},{"id":"si44682","class":"TODO::Senthil","roles":{"click":{"subtype":"button","question":"Slide44368q6"},"answer":{"title":"dummy title","index":-1,"score":{}}}},{"id":"si44678_a","class":"TODO::Senthil","roles":{"answer":{"title":"The carboplatin dose is not ordered.\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si44693","class":"TODO::Senthil","title":"D) ","roles":{"textData":{}}},{"id":"si44697","class":"TODO::Senthil","title":"The BSA. ","roles":{"textData":{}}},{"id":"si44697","class":"TODO::Senthil","roles":{"click":{"subtype":"button","question":"Slide44368q6"},"answer":{"title":"dummy title","index":-1,"score":{}}}},{"id":"si44693_a","class":"TODO::Senthil","roles":{"answer":{"title":"The BSA.\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si44708","class":"TODO::Senthil","title":"E) ","roles":{"textData":{}}},{"id":"si44712","class":"TODO::Senthil","title":"The etoposide is ordered for the wrong days. ","roles":{"textData":{}}},{"id":"si44712","class":"TODO::Senthil","roles":{"click":{"subtype":"button","question":"Slide44368q6"},"answer":{"title":"dummy title","index":-1,"score":{}}}},{"id":"si44708_a","class":"TODO::Senthil","roles":{"answer":{"title":"The etoposide is ordered for the wrong days.\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si44723","class":"TODO::Senthil","title":"F) ","roles":{"textData":{}}},{"id":"si44727","class":"TODO::Senthil","title":"The order is not signed by the doctor. ","roles":{"textData":{}}},{"id":"si44727","class":"TODO::Senthil","roles":{"click":{"subtype":"button","question":"Slide44368q6"},"answer":{"title":"dummy title","index":-1,"score":{}}}},{"id":"si44723_a","class":"TODO::Senthil","roles":{"answer":{"title":"The order is not signed by the doctor.\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si44447","class":"TODO::Senthil","roles":{}},{"id":"si44455","class":"TODO::Senthil","title":"Submit ","roles":{"click":{"subtype":"submit","question":"Slide44368q6","for":"Slide44368q6"},"textData":{}}},{"id":"si44435","class":"TODO::Senthil","title":"Congratulations.   You selected the correct response.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si44439","class":"TODO::Senthil","title":"You did not select the correct response.  Please review the reviewing prescriptions section in the eLearning guide.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si44443","class":"TODO::Senthil","title":"You must answer the question before continuing. ","roles":{"textData":{}}},{"id":"Slide44368","class":"Question Slide","instance":"","thumbnail":"","children":["si15354","Text_Caption_530","Text_Caption_531","si44401","si44420","si44431","si44682","si44697","si44712","si44727","si44455","si44443"],"roles":{"slide":{"durationInFrames":90},"navigation":{"navid":"Slide44368"},"question":{"interactionId":"44381","quizId":455,"title":"Multiple Choice","text":"Your patient’s height is 160cm, weight is 62.5kg. She is due to receive cycle 1 of ICE, for non-Hodgkin Lymphoma. First calculate her BSA using the eviQ calculator and then calculate the antineoplastic drug doses she is to receive. \r\rReview the prescription chart to determine what is incorrect on the prescription chart. Note: More than one answer may be correct.\r","type":0,"interactionType":"choice","ramdomized":false,"correctAnswers":["A","B","C","D"],"score":{"weight":1,"penalty":0}}}},{"id":"si44502","class":"TODO::Senthil","title":"As you prepare to administer your patients antineoplastic drugs, you check the drug dose supplied against the prescription. The prescription reads 100 mg and you are supplied with 140 mg. You checked the protocol and 140 mg is the correct dose for your patient.   What are the most appropriate actions? Note: more than one answer may be correct ","roles":{"textData":{}}},{"id":"si44517","class":"TODO::Senthil","title":"A) ","roles":{"textData":{}}},{"id":"si44521","class":"TODO::Senthil","title":"Administer the medication. ","roles":{"textData":{}}},{"id":"si44521","class":"TODO::Senthil","roles":{"click":{"subtype":"button","question":"Slide44469q7"},"answer":{"title":"dummy title","index":-1,"score":{}}}},{"id":"si44517_a","class":"TODO::Senthil","roles":{"answer":{"title":"Administer the medication.\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si44528","class":"TODO::Senthil","title":"B) ","roles":{"textData":{}}},{"id":"si44532","class":"TODO::Senthil","title":"Do not administer the medication, seek a correct prescription. ","roles":{"textData":{}}},{"id":"si44532","class":"TODO::Senthil","roles":{"click":{"subtype":"button","question":"Slide44469q7"},"answer":{"title":"dummy title","index":-1,"score":{}}}},{"id":"si44528_a","class":"TODO::Senthil","roles":{"answer":{"title":"Do not administer the medication, seek a correct prescription.\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si44788","class":"TODO::Senthil","title":"C) ","roles":{"textData":{}}},{"id":"si44792","class":"TODO::Senthil","title":"Tell the patient that you are going to administer the medication and get the prescription changed later.  ","roles":{"textData":{}}},{"id":"si44792","class":"TODO::Senthil","roles":{"click":{"subtype":"button","question":"Slide44469q7"},"answer":{"title":"dummy title","index":-1,"score":{}}}},{"id":"si44788_a","class":"TODO::Senthil","roles":{"answer":{"title":"Tell the patient that you are going to administer the medication and get the prescription changed later. \r","index":"Not implemented","score":{"weight":0}}}},{"id":"si44803","class":"TODO::Senthil","title":"D) ","roles":{"textData":{}}},{"id":"si44807","class":"TODO::Senthil","title":"Lodge an incident as per local policy.  ","roles":{"textData":{}}},{"id":"si44807","class":"TODO::Senthil","roles":{"click":{"subtype":"button","question":"Slide44469q7"},"answer":{"title":"dummy title","index":-1,"score":{}}}},{"id":"si44803_a","class":"TODO::Senthil","roles":{"answer":{"title":"Lodge an incident as per local policy. \r","index":"Not implemented","score":{"weight":0}}}},{"id":"si44548","class":"TODO::Senthil","roles":{}},{"id":"si44556","class":"TODO::Senthil","title":"Submit ","roles":{"click":{"subtype":"submit","question":"Slide44469q7","for":"Slide44469q7"},"textData":{}}},{"id":"si44536","class":"TODO::Senthil","title":"Congratulations.   You selected the correct response.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si44540","class":"TODO::Senthil","title":"You did not select the correct response.  Please review the reviewing prescriptions section in the eLearning guide.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si44544","class":"TODO::Senthil","title":"You must answer the question before continuing. ","roles":{"textData":{}}},{"id":"Slide44469","class":"Question Slide","instance":"","thumbnail":"","children":["si15354","si44502","si44521","si44532","si44792","si44807","si44556","si44544"],"roles":{"slide":{"durationInFrames":90},"navigation":{"navid":"Slide44469"},"question":{"interactionId":"44482","quizId":455,"title":"Multiple Choice","text":"As you prepare to administer your patients antineoplastic drugs, you check the drug dose supplied against the prescription. The prescription reads 100 mg and you are supplied with 140 mg. You checked the protocol and 140 mg is the correct dose for your patient. \r\rWhat are the most appropriate actions? Note: more than one answer may be correct\r","type":0,"interactionType":"choice","ramdomized":false,"correctAnswers":["B","D"],"score":{"weight":1,"penalty":0}}}},{"id":"si44603","class":"TODO::Senthil","title":"In which of the following circumstances would you lodge an incident report? ","roles":{"textData":{}}},{"id":"si44618","class":"TODO::Senthil","title":"A) ","roles":{"textData":{}}},{"id":"si44622","class":"TODO::Senthil","title":"The drug should be administered intravenously but is prescribed intramuscularly. ","roles":{"textData":{}}},{"id":"si44618_a","class":"TODO::Senthil","roles":{"answer":{"title":"The drug should be administered intravenously but is prescribed intramuscularly.\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si44629","class":"TODO::Senthil","title":"B) ","roles":{"textData":{}}},{"id":"si44633","class":"TODO::Senthil","title":"The dose of the drug is incorrect. ","roles":{"textData":{}}},{"id":"si44629_a","class":"TODO::Senthil","roles":{"answer":{"title":"The dose of the drug is incorrect.\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si44830","class":"TODO::Senthil","title":"C) ","roles":{"textData":{}}},{"id":"si44834","class":"TODO::Senthil","title":"The prescriber’s signature is missing. ","roles":{"textData":{}}},{"id":"si44830_a","class":"TODO::Senthil","roles":{"answer":{"title":"The prescriber’s signature is missing.\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si44845","class":"TODO::Senthil","title":"D) ","roles":{"textData":{}}},{"id":"si44849","class":"TODO::Senthil","title":"A drug is prescribed as 16 mg and should be prescribed as 160 mg. ","roles":{"textData":{}}},{"id":"si44845_a","class":"TODO::Senthil","roles":{"answer":{"title":"A drug is prescribed as 16 mg and should be prescribed as 160 mg.\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si44860","class":"TODO::Senthil","title":"E) ","roles":{"textData":{}}},{"id":"si44864","class":"TODO::Senthil","title":"All of the above are correct.  ","roles":{"textData":{}}},{"id":"si44860_a","class":"TODO::Senthil","roles":{"answer":{"title":"All of the above are correct. \r","index":"Not implemented","score":{"weight":10}}}},{"id":"si44649","class":"TODO::Senthil","roles":{}},{"id":"si44657","class":"TODO::Senthil","title":"Submit ","roles":{"click":{"subtype":"submit","question":"Slide44570q8","for":"Slide44570q8"},"textData":{}}},{"id":"si44637","class":"TODO::Senthil","title":"Congratulations.   You selected the correct response.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si44641","class":"TODO::Senthil","title":"You did not select the correct response.  Please review the notification of errors/incidents section in the eLearning guide.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si44645","class":"TODO::Senthil","title":"You must answer the question before continuing. ","roles":{"textData":{}}},{"id":"Slide44570","class":"Question Slide","instance":"","thumbnail":"","children":["si15354","si44603","si44622","si44633","si44834","si44849","si44864","si44657","si44645"],"roles":{"slide":{"durationInFrames":90},"navigation":{"navid":"Slide44570"},"question":{"interactionId":"44583","quizId":455,"title":"Multiple Choice","text":"In which of the following circumstances would you lodge an incident report?\r","type":0,"interactionType":"choice","ramdomized":false,"correctAnswers":["E"],"score":{"weight":1,"penalty":0}}}},{"id":"Slide44216","class":"Random Question Slide","instance":"","thumbnail":"","roles":{"slide":{"durationInFrames":0},"navigation":{"navid":"Slide44216"}}},{"id":"Text_Caption_528","class":"TODO::Senthil","instance":"Text_Caption_528","title":"Results for: $$learnername$$ ","roles":{"textData":{}}},{"id":"Text_Caption_529","class":"TODO::Senthil","instance":"Text_Caption_529","title":"Date: $$date$$ ","roles":{"textData":{}}},{"id":"Text_Caption_600","class":"TODO::Senthil","instance":"Text_Caption_600","title":"When printing this results page: set the printer to print landscape if you are not able to print this page please take a screenshot or picture as you will not be able to save or return to this page  ","roles":{"textData":{}}},{"id":"Image_141","class":"TODO::Senthil","instance":"Image_141","roles":{}},{"id":"si17975","class":"TODO::Senthil","roles":{}},{"id":"si17983","class":"TODO::Senthil","roles":{}},{"id":"si17991","class":"TODO::Senthil","roles":{}},{"id":"si17999","class":"TODO::Senthil","roles":{}},{"id":"si18007","class":"TODO::Senthil","roles":{}},{"id":"si17964","class":"TODO::Senthil","title":"eQuiz: Reviewing prescriptions and protocols ","roles":{"textData":{}}},{"id":"si17971","class":"TODO::Senthil","title":"You Scored: ","roles":{"textData":{}}},{"id":"si17979","class":"TODO::Senthil","title":"Maximum Score: ","roles":{"textData":{}}},{"id":"si17987","class":"TODO::Senthil","title":"Correct Questions: ","roles":{"textData":{}}},{"id":"si17995","class":"TODO::Senthil","title":"Total Questions: ","roles":{"textData":{}}},{"id":"si18003","class":"TODO::Senthil","title":"Accuracy: ","roles":{"textData":{}}},{"id":"si18019","class":"TODO::Senthil","roles":{}},{"id":"Slide17954","class":"Question Slide","instance":"","thumbnail":"","children":[],"roles":{"slide":{"durationInFrames":90},"navigation":{"navid":"Slide17954"}}},{"id":"Text_Caption_532","class":"TODO::Senthil","instance":"Text_Caption_532","title":"Link to Ovarian Recurrent Carbolplatin and Gemcitabine  ","roles":{"textData":{}}},{"id":"si36792","class":"TODO::Senthil","title":"A patient’s height is 150 cm, weight is 52 kg. She is receiving gemcitabine at a dose of 1000mg/m2 for Recurrent Ovarian Cancer. DOB: 01 / January (age 46).  Calculate her BSA using the eviQ calculator and then calculate her dose of gemcitabine. ","roles":{"textData":{}}},{"id":"si36807","class":"TODO::Senthil","title":"A) ","roles":{"textData":{}}},{"id":"si36811","class":"TODO::Senthil","title":"1460 mg ","roles":{"textData":{}}},{"id":"si36807_a","class":"TODO::Senthil","roles":{"answer":{"title":"1460 mg\r","index":"Not implemented","score":{"weight":10}}}},{"id":"si36818","class":"TODO::Senthil","title":"B) ","roles":{"textData":{}}},{"id":"si36822","class":"TODO::Senthil","title":"1640 mg ","roles":{"textData":{}}},{"id":"si36818_a","class":"TODO::Senthil","roles":{"answer":{"title":"1640 mg\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si37226","class":"TODO::Senthil","title":"C) ","roles":{"textData":{}}},{"id":"si37230","class":"TODO::Senthil","title":"1046 mg ","roles":{"textData":{}}},{"id":"si37226_a","class":"TODO::Senthil","roles":{"answer":{"title":"1046 mg\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si37241","class":"TODO::Senthil","title":"D) ","roles":{"textData":{}}},{"id":"si37245","class":"TODO::Senthil","title":"1000 mg ","roles":{"textData":{}}},{"id":"si37241_a","class":"TODO::Senthil","roles":{"answer":{"title":"1000 mg\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si36838","class":"TODO::Senthil","roles":{}},{"id":"si36846","class":"TODO::Senthil","title":"Submit ","roles":{"click":{"subtype":"submit","question":"Slide36759q","for":"Slide36759q"},"textData":{}}},{"id":"si36826","class":"TODO::Senthil","title":"Congratulations.   You selected the correct response.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si36830","class":"TODO::Senthil","title":"You did not select the correct response.  Please review the calculating BSA & antineoplastic drug doses section in the eLearning guide.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si36834","class":"TODO::Senthil","title":"You must answer the question before continuing ","roles":{"textData":{}}},{"id":"Slide36759","class":"Question Slide","instance":"BSA","thumbnail":"","children":["si15354","Text_Caption_532","si36792","si36811","si36822","si37230","si37245","si36846","si36834"],"roles":{"slide":{"durationInFrames":90},"navigation":{"navid":"Slide36759"},"question":{"interactionId":"36772","quizId":-1,"title":"Multiple Choice","text":"A patient’s height is 150 cm, weight is 52 kg. She is receiving gemcitabine at a dose of 1000mg/m2 for Recurrent Ovarian Cancer. DOB: 01 / January (age 46).\r\rCalculate her BSA using the eviQ calculator and then calculate her dose of gemcitabine.\r","type":0,"pool":499,"interactionType":"choice","ramdomized":false,"correctAnswers":["A"],"score":{"weight":10,"penalty":0}}}},{"id":"Text_Caption_533","class":"TODO::Senthil","instance":"Text_Caption_533","title":"Link to Breast AC protocol  ","roles":{"textData":{}}},{"id":"si37278","class":"TODO::Senthil","instance":"Text_Caption_28","roles":{}},{"id":"si37290","class":"TODO::Senthil","instance":"Text_Caption_38","title":"A patient’s height is 160 cm, weight is 62.5 kg. She is to receive cyclophosphamide 600 mg/m2 as part of the Breast Adjuvant AC. DOB: 01 January (age 54).   Calculate her BSA using the eviQ calculator and then calculate her dose of cyclophosphamide. ","roles":{"textData":{}}},{"id":"si37301","class":"TODO::Senthil","instance":"Text_Caption_39","title":"A) ","roles":{"textData":{}}},{"id":"si37305","class":"TODO::Senthil","instance":"Text_Caption_49","title":"960 mg ","roles":{"textData":{}}},{"id":"si37301_a","class":"TODO::Senthil","instance":"2","roles":{"answer":{"title":"960 mg\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si37312","class":"TODO::Senthil","instance":"Text_Caption_50","title":"B) ","roles":{"textData":{}}},{"id":"si37316","class":"TODO::Senthil","instance":"Text_Caption_51","title":"900 mg ","roles":{"textData":{}}},{"id":"si37312_a","class":"TODO::Senthil","instance":"4","roles":{"answer":{"title":"900 mg\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si37326","class":"TODO::Senthil","instance":"Text_Caption_52","title":"C) ","roles":{"textData":{}}},{"id":"si37330","class":"TODO::Senthil","instance":"Text_Caption_53","title":"1000 mg ","roles":{"textData":{}}},{"id":"si37326_a","class":"TODO::Senthil","instance":"6","roles":{"answer":{"title":"1000 mg\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si37337","class":"TODO::Senthil","instance":"Text_Caption_54","title":"D) ","roles":{"textData":{}}},{"id":"si37341","class":"TODO::Senthil","instance":"Text_Caption_55","title":"990 mg ","roles":{"textData":{}}},{"id":"si37337_a","class":"TODO::Senthil","instance":"8","roles":{"answer":{"title":"990 mg\r","index":"Not implemented","score":{"weight":10}}}},{"id":"si37414","class":"TODO::Senthil","instance":"Button_1","title":"Submit ","roles":{"click":{"subtype":"submit","question":"Slide37424q","for":"Slide37424q"},"textData":{}}},{"id":"si37368","class":"TODO::Senthil","instance":"Text_Caption_56","title":"Congratulations.   You selected the correct response.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si37376","class":"TODO::Senthil","instance":"Text_Caption_57","title":"You did not select the correct response.  Please review the calculating BSA & antineoplastic drug doses section in the eLearning guide.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si37384","class":"TODO::Senthil","instance":"Text_Caption_58","title":"You must answer the question before continuing ","roles":{"textData":{}}},{"id":"Slide37424","class":"Question Slide","instance":"BSA","thumbnail":"","children":["si15354","Text_Caption_533","si37290","si37305","si37316","si37330","si37341","si37414","si37384"],"roles":{"slide":{"durationInFrames":90},"navigation":{"navid":"Slide37424"},"question":{"interactionId":"37271","quizId":-1,"title":"Multiple Choice","text":"A patient’s height is 160 cm, weight is 62.5 kg. She is to receive cyclophosphamide 600 mg/m2 as part of the Breast Adjuvant AC. DOB: 01 January (age 54). \r\rCalculate her BSA using the eviQ calculator and then calculate her dose of cyclophosphamide.\r","type":0,"pool":499,"interactionType":"choice","ramdomized":false,"correctAnswers":["D"],"score":{"weight":10,"penalty":0}}}},{"id":"si37454","class":"TODO::Senthil","instance":"Text_Caption_60","roles":{}},{"id":"si37466","class":"TODO::Senthil","instance":"Text_Caption_61","title":"A patient’s height is 170 cm, weight is 75 kg. She is receiving cycle 1 dacarbazine 375 mg/m2 as part of the ABVD protocol for early stage Hodgkin Lymphoma. DOB: 01 January (age 36).  Calculate her BSA using the eviQ calculator then calculate her dose of dacarbazine. ","roles":{"textData":{}}},{"id":"si37477","class":"TODO::Senthil","instance":"Text_Caption_62","title":"A) ","roles":{"textData":{}}},{"id":"si37481","class":"TODO::Senthil","instance":"Text_Caption_63","title":"697.5 mg ","roles":{"textData":{}}},{"id":"si37477_a","class":"TODO::Senthil","instance":"11","roles":{"answer":{"title":"697.5 mg\r","index":"Not implemented","score":{"weight":10}}}},{"id":"si37488","class":"TODO::Senthil","instance":"Text_Caption_64","title":"B) ","roles":{"textData":{}}},{"id":"si37492","class":"TODO::Senthil","instance":"Text_Caption_65","title":"679.5 mg ","roles":{"textData":{}}},{"id":"si37488_a","class":"TODO::Senthil","instance":"13","roles":{"answer":{"title":"679.5 mg\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si37502","class":"TODO::Senthil","instance":"Text_Caption_66","title":"C) ","roles":{"textData":{}}},{"id":"si37506","class":"TODO::Senthil","instance":"Text_Caption_67","title":"745.5 mg ","roles":{"textData":{}}},{"id":"si37502_a","class":"TODO::Senthil","instance":"15","roles":{"answer":{"title":"745.5 mg\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si37513","class":"TODO::Senthil","instance":"Text_Caption_68","title":"D) ","roles":{"textData":{}}},{"id":"si37517","class":"TODO::Senthil","instance":"Text_Caption_69","title":"754.5 mg ","roles":{"textData":{}}},{"id":"si37513_a","class":"TODO::Senthil","instance":"17","roles":{"answer":{"title":"754.5 mg\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si37590","class":"TODO::Senthil","instance":"Button_2","title":"Submit ","roles":{"click":{"subtype":"submit","question":"Slide37600q","for":"Slide37600q"},"textData":{}}},{"id":"si37544","class":"TODO::Senthil","instance":"Text_Caption_70","title":"Congratulations.   You selected the correct response.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si37552","class":"TODO::Senthil","instance":"Text_Caption_71","title":"You did not select the correct response.  Please review the calculating BSA & antineoplastic drug doses section in the eLearning guide.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si37560","class":"TODO::Senthil","instance":"Text_Caption_72","title":"You must answer the question before continuing ","roles":{"textData":{}}},{"id":"Slide37600","class":"Question Slide","instance":"BSA","thumbnail":"","children":["si15354","si37466","si37481","si37492","si37506","si37517","si37590","si37560"],"roles":{"slide":{"durationInFrames":90},"navigation":{"navid":"Slide37600"},"question":{"interactionId":"37447","quizId":-1,"title":"Multiple Choice","text":"A patient’s height is 170 cm, weight is 75 kg. She is receiving cycle 1 dacarbazine 375 mg/m2 as part of the ABVD protocol for early stage Hodgkin Lymphoma. DOB: 01 January (age 36).\r\rCalculate her BSA using the eviQ calculator then calculate her dose of dacarbazine.\r","type":0,"pool":499,"interactionType":"choice","ramdomized":false,"correctAnswers":["A"],"score":{"weight":10,"penalty":0}}}},{"id":"Text_Caption_534","class":"TODO::Senthil","instance":"Text_Caption_534","title":"Link to Ovarian Recurrent Carbolplatin and Gemcitabine  ","roles":{"textData":{}}},{"id":"si37630","class":"TODO::Senthil","instance":"Text_Caption_74","roles":{}},{"id":"si37642","class":"TODO::Senthil","instance":"Text_Caption_75","title":"A patient’s height is 150 cm, weight is 52 kg. She is to receive gemcitabine for Recurrent Ovarian Cancer at a dose of 1000 mg/m2. DOB: 01 / January (age 46).  Due to toxicities, she is to receive a 25% dose reduction.   Calculate her BSA using the eviQ calculator and then calculate her dose of gemcitabine. ","roles":{"textData":{}}},{"id":"si37653","class":"TODO::Senthil","instance":"Text_Caption_76","title":"A) ","roles":{"textData":{}}},{"id":"si37657","class":"TODO::Senthil","instance":"Text_Caption_77","title":"1195 mg ","roles":{"textData":{}}},{"id":"si37653_a","class":"TODO::Senthil","instance":"20","roles":{"answer":{"title":"1195 mg\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si37664","class":"TODO::Senthil","instance":"Text_Caption_78","title":"B) ","roles":{"textData":{}}},{"id":"si37668","class":"TODO::Senthil","instance":"Text_Caption_79","title":"1095 mg ","roles":{"textData":{}}},{"id":"si37664_a","class":"TODO::Senthil","instance":"22","roles":{"answer":{"title":"1095 mg\r","index":"Not implemented","score":{"weight":10}}}},{"id":"si37678","class":"TODO::Senthil","instance":"Text_Caption_80","title":"C) ","roles":{"textData":{}}},{"id":"si37682","class":"TODO::Senthil","instance":"Text_Caption_81","title":"1168 mg ","roles":{"textData":{}}},{"id":"si37678_a","class":"TODO::Senthil","instance":"24","roles":{"answer":{"title":"1168 mg\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si37689","class":"TODO::Senthil","instance":"Text_Caption_82","title":"D) ","roles":{"textData":{}}},{"id":"si37693","class":"TODO::Senthil","instance":"Text_Caption_83","title":"1000 mg ","roles":{"textData":{}}},{"id":"si37689_a","class":"TODO::Senthil","instance":"26","roles":{"answer":{"title":"1000 mg\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si37766","class":"TODO::Senthil","instance":"Button_3","title":"Submit ","roles":{"click":{"subtype":"submit","question":"Slide37776q","for":"Slide37776q"},"textData":{}}},{"id":"si37720","class":"TODO::Senthil","instance":"Text_Caption_84","title":"Congratulations.   You selected the correct response.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si37728","class":"TODO::Senthil","instance":"Text_Caption_85","title":"You did not select the correct response.  Please review the calculating reduced antineoplastic drug doses section in the eLearning guide.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si37736","class":"TODO::Senthil","instance":"Text_Caption_86","title":"You must answer the question before continuing ","roles":{"textData":{}}},{"id":"Slide37776","class":"Question Slide","instance":"Dose modification","thumbnail":"","children":["si15354","Text_Caption_534","si37642","si37657","si37668","si37682","si37693","si37766","si37736"],"roles":{"slide":{"durationInFrames":90},"navigation":{"navid":"Slide37776"},"question":{"interactionId":"37623","quizId":-1,"title":"Multiple Choice","text":"A patient’s height is 150 cm, weight is 52 kg. She is to receive gemcitabine for Recurrent Ovarian Cancer at a dose of 1000 mg/m2. DOB: 01 / January (age 46).\r\rDue to toxicities, she is to receive a 25% dose reduction. \r\rCalculate her BSA using the eviQ calculator and then calculate her dose of gemcitabine.\r","type":0,"pool":499,"interactionType":"choice","ramdomized":false,"correctAnswers":["B"],"score":{"weight":10,"penalty":0}}}},{"id":"Text_Caption_535","class":"TODO::Senthil","instance":"Text_Caption_535","title":"Link to Breast AC protocol  ","roles":{"textData":{}}},{"id":"si37806","class":"TODO::Senthil","instance":"Text_Caption_88","roles":{}},{"id":"si37818","class":"TODO::Senthil","instance":"Text_Caption_89","title":"A patient’s height is 160 cm, weight is 62.5 kg. She is to receive cyclophosphamide 600 mg/m2 as part of the Breast Adjuvant AC protocol. DOB: 01 / January (age 46).  Due to toxicities she is to have a 20% dose reduction.   Calculate her BSA using the eviQ calculator and then calculate the dose. ","roles":{"textData":{}}},{"id":"si37829","class":"TODO::Senthil","instance":"Text_Caption_90","title":"A) ","roles":{"textData":{}}},{"id":"si37833","class":"TODO::Senthil","instance":"Text_Caption_91","title":"700 mg ","roles":{"textData":{}}},{"id":"si37829_a","class":"TODO::Senthil","instance":"29","roles":{"answer":{"title":"700 mg\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si37840","class":"TODO::Senthil","instance":"Text_Caption_92","title":"B) ","roles":{"textData":{}}},{"id":"si37844","class":"TODO::Senthil","instance":"Text_Caption_93","title":"600 mg ","roles":{"textData":{}}},{"id":"si37840_a","class":"TODO::Senthil","instance":"31","roles":{"answer":{"title":"600 mg\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si37854","class":"TODO::Senthil","instance":"Text_Caption_94","title":"C) ","roles":{"textData":{}}},{"id":"si37858","class":"TODO::Senthil","instance":"Text_Caption_95","title":"742.5 mg ","roles":{"textData":{}}},{"id":"si37854_a","class":"TODO::Senthil","instance":"33","roles":{"answer":{"title":"742.5 mg\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si37865","class":"TODO::Senthil","instance":"Text_Caption_96","title":"D) ","roles":{"textData":{}}},{"id":"si37869","class":"TODO::Senthil","instance":"Text_Caption_97","title":"792 mg ","roles":{"textData":{}}},{"id":"si37865_a","class":"TODO::Senthil","instance":"35","roles":{"answer":{"title":"792 mg\r","index":"Not implemented","score":{"weight":10}}}},{"id":"si37942","class":"TODO::Senthil","instance":"Button_4","title":"Submit ","roles":{"click":{"subtype":"submit","question":"Slide37952q","for":"Slide37952q"},"textData":{}}},{"id":"si37896","class":"TODO::Senthil","instance":"Text_Caption_98","title":"Congratulations.   You selected the correct response.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si37904","class":"TODO::Senthil","instance":"Text_Caption_99","title":"You did not select the correct response.  Please review the calculating reduced antineoplastic drug doses section in the eLearning guide.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si37912","class":"TODO::Senthil","instance":"Text_Caption_100","title":"You must answer the question before continuing ","roles":{"textData":{}}},{"id":"Slide37952","class":"Question Slide","instance":"Dose modification","thumbnail":"","children":["si15354","Text_Caption_535","si37818","si37833","si37844","si37858","si37869","si37942","si37912"],"roles":{"slide":{"durationInFrames":90},"navigation":{"navid":"Slide37952"},"question":{"interactionId":"37799","quizId":-1,"title":"Multiple Choice","text":"A patient’s height is 160 cm, weight is 62.5 kg. She is to receive cyclophosphamide 600 mg/m2 as part of the Breast Adjuvant AC protocol. DOB: 01 / January (age 46).\r\rDue to toxicities she is to have a 20% dose reduction. \r\rCalculate her BSA using the eviQ calculator and then calculate the dose.\r","type":0,"pool":499,"interactionType":"choice","ramdomized":false,"correctAnswers":["D"],"score":{"weight":10,"penalty":0}}}},{"id":"Text_Caption_536","class":"TODO::Senthil","instance":"Text_Caption_536","title":"Link to ABVD protocol  ","roles":{"textData":{}}},{"id":"si37982","class":"TODO::Senthil","instance":"Text_Caption_102","roles":{}},{"id":"si37994","class":"TODO::Senthil","instance":"Text_Caption_103","title":"A patient’s height is 170 cm, weight is 75 kg. She is receiving cycle 1 dacarbazine 375 mg/m2 as part of the ABVD protocol for early stage Hodgkin Lymphoma. DOB: 01 January (age 36). Due to hepatic impairment, she is to receive a 25% dose reduction.  Calculate her BSA using the eviQ calculator then calculate her dose of dacarbazine.     ","roles":{"textData":{}}},{"id":"si38005","class":"TODO::Senthil","instance":"Text_Caption_104","title":"A) ","roles":{"textData":{}}},{"id":"si38009","class":"TODO::Senthil","instance":"Text_Caption_105","title":"523.12 mg ","roles":{"textData":{}}},{"id":"si38005_a","class":"TODO::Senthil","instance":"38","roles":{"answer":{"title":"523.12 mg\r","index":"Not implemented","score":{"weight":10}}}},{"id":"si38016","class":"TODO::Senthil","instance":"Text_Caption_106","title":"B) ","roles":{"textData":{}}},{"id":"si38020","class":"TODO::Senthil","instance":"Text_Caption_107","title":"551.25 mg ","roles":{"textData":{}}},{"id":"si38016_a","class":"TODO::Senthil","instance":"40","roles":{"answer":{"title":"551.25 mg\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si38030","class":"TODO::Senthil","instance":"Text_Caption_108","title":"C) ","roles":{"textData":{}}},{"id":"si38034","class":"TODO::Senthil","instance":"Text_Caption_109","title":"507.31 mg ","roles":{"textData":{}}},{"id":"si38030_a","class":"TODO::Senthil","instance":"42","roles":{"answer":{"title":"507.31 mg\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si38041","class":"TODO::Senthil","instance":"Text_Caption_110","title":"D) ","roles":{"textData":{}}},{"id":"si38045","class":"TODO::Senthil","instance":"Text_Caption_111","title":"547.46 mg ","roles":{"textData":{}}},{"id":"si38041_a","class":"TODO::Senthil","instance":"44","roles":{"answer":{"title":"547.46 mg\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si38118","class":"TODO::Senthil","instance":"Button_5","title":"Submit ","roles":{"click":{"subtype":"submit","question":"Slide38128q","for":"Slide38128q"},"textData":{}}},{"id":"si38072","class":"TODO::Senthil","instance":"Text_Caption_112","title":"Congratulations.   You selected the correct response.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si38080","class":"TODO::Senthil","instance":"Text_Caption_113","title":"You did not select the correct response.  Please review the calculating reduced antineoplastic drug doses section in the eLearning guide.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si38088","class":"TODO::Senthil","instance":"Text_Caption_114","title":"You must answer the question before continuing ","roles":{"textData":{}}},{"id":"Slide38128","class":"Question Slide","instance":"Dose modification","thumbnail":"","children":["si15354","Text_Caption_536","si37994","si38009","si38020","si38034","si38045","si38118","si38088"],"roles":{"slide":{"durationInFrames":90},"navigation":{"navid":"Slide38128"},"question":{"interactionId":"37975","quizId":-1,"title":"Multiple Choice","text":"A patient’s height is 170 cm, weight is 75 kg. She is receiving cycle 1 dacarbazine 375 mg/m2 as part of the ABVD protocol for early stage Hodgkin Lymphoma. DOB: 01 January (age 36). Due to hepatic impairment, she is to receive a 25% dose reduction.\r\rCalculate her BSA using the eviQ calculator then calculate her dose of dacarbazine.  \r\r\r","type":0,"pool":499,"interactionType":"choice","ramdomized":false,"correctAnswers":["A"],"score":{"weight":10,"penalty":0}}}},{"id":"si42033","class":"TODO::Senthil","instance":"Text_Caption_424","roles":{}},{"id":"si42045","class":"TODO::Senthil","instance":"Text_Caption_425","title":"The frequency of a protocol refers to: ","roles":{"textData":{}}},{"id":"si42056","class":"TODO::Senthil","instance":"Text_Caption_426","title":"A) ","roles":{"textData":{}}},{"id":"si42060","class":"TODO::Senthil","instance":"Text_Caption_427","title":"The time interval between day 1 of each cycle ","roles":{"textData":{}}},{"id":"si42056_a","class":"TODO::Senthil","instance":"245","roles":{"answer":{"title":"The time interval between day 1 of each cycle\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si42067","class":"TODO::Senthil","instance":"Text_Caption_428","title":"B) ","roles":{"textData":{}}},{"id":"si42071","class":"TODO::Senthil","instance":"Text_Caption_429","title":"The number of times a drug is administered ","roles":{"textData":{}}},{"id":"si42067_a","class":"TODO::Senthil","instance":"247","roles":{"answer":{"title":"The number of times a drug is administered\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si42078","class":"TODO::Senthil","instance":"Text_Caption_430","title":"C) ","roles":{"textData":{}}},{"id":"si42082","class":"TODO::Senthil","instance":"Text_Caption_431","title":"The time that a drug is administered for ","roles":{"textData":{}}},{"id":"si42078_a","class":"TODO::Senthil","instance":"249","roles":{"answer":{"title":"The time that a drug is administered for\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si42089","class":"TODO::Senthil","instance":"Text_Caption_432","title":"D) ","roles":{"textData":{}}},{"id":"si42093","class":"TODO::Senthil","instance":"Text_Caption_433","title":"The drug used in the protocol ","roles":{"textData":{}}},{"id":"si42089_a","class":"TODO::Senthil","instance":"251","roles":{"answer":{"title":"The drug used in the protocol\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si42166","class":"TODO::Senthil","instance":"Button_77","title":"Submit ","roles":{"click":{"subtype":"submit","question":"Slide42176q","for":"Slide42176q"},"textData":{}}},{"id":"si42120","class":"TODO::Senthil","instance":"Text_Caption_434","title":"Congratulations.   You selected the correct response.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si42128","class":"TODO::Senthil","instance":"Text_Caption_435","title":"You did not select the correct response.  Please review Reviewing treatment schedule section in the eLearning guide.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si42136","class":"TODO::Senthil","instance":"Text_Caption_436","title":"You must answer the question before continuing ","roles":{"textData":{}}},{"id":"Slide42176","class":"Question Slide","instance":"CLA 1 and 4","thumbnail":"","children":["si15354","si42045","si42060","si42071","si42082","si42093","si42166","si42136"],"roles":{"slide":{"durationInFrames":90},"navigation":{"navid":"Slide42176"},"question":{"interactionId":"equiz_module_399025","quizId":-1,"title":"Multiple Choice","text":"The frequency of a protocol refers to:\r","type":0,"pool":499,"interactionType":"choice","ramdomized":false,"correctAnswers":["A"],"score":{"weight":0,"penalty":0}}}},{"id":"si42413","class":"TODO::Senthil","instance":"Text_Caption_452","roles":{}},{"id":"si42425","class":"TODO::Senthil","instance":"Text_Caption_453","title":"How would you ensure that a patient’s absolute neutrophil count (ANC) is adequate to proceed with antineoplastic drug administration? ","roles":{"textData":{}}},{"id":"si42436","class":"TODO::Senthil","instance":"Text_Caption_454","title":"A) ","roles":{"textData":{}}},{"id":"si42440","class":"TODO::Senthil","instance":"Text_Caption_455","title":"Check FBC prior to treatment ","roles":{"textData":{}}},{"id":"si42436_a","class":"TODO::Senthil","roles":{"answer":{"title":"Check FBC prior to treatment\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si42447","class":"TODO::Senthil","instance":"Text_Caption_456","title":"B) ","roles":{"textData":{}}},{"id":"si42451","class":"TODO::Senthil","instance":"Text_Caption_457","title":"Check LFT on day of treatment ","roles":{"textData":{}}},{"id":"si42447_a","class":"TODO::Senthil","roles":{"answer":{"title":"Check LFT on day of treatment\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si42458","class":"TODO::Senthil","instance":"Text_Caption_458","title":"C) ","roles":{"textData":{}}},{"id":"si42462","class":"TODO::Senthil","instance":"Text_Caption_459","title":"Check the protocol for the recommended range ","roles":{"textData":{}}},{"id":"si42458_a","class":"TODO::Senthil","roles":{"answer":{"title":"Check the protocol for the recommended range\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si42469","class":"TODO::Senthil","instance":"Text_Caption_460","title":"D) ","roles":{"textData":{}}},{"id":"si42473","class":"TODO::Senthil","instance":"Text_Caption_461","title":"Both A and C are correct ","roles":{"textData":{}}},{"id":"si42469_a","class":"TODO::Senthil","roles":{"answer":{"title":"Both A and C are correct\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si42480","class":"TODO::Senthil","instance":"Text_Caption_462","title":"E) ","roles":{"textData":{}}},{"id":"si42484","class":"TODO::Senthil","instance":"Text_Caption_463","title":"Both B and C are correct ","roles":{"textData":{}}},{"id":"si42480_a","class":"TODO::Senthil","roles":{"answer":{"title":"Both B and C are correct\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si42557","class":"TODO::Senthil","instance":"Button_79","title":"Submit ","roles":{"click":{"subtype":"submit","question":"Slide42567q","for":"Slide42567q"},"textData":{}}},{"id":"si42511","class":"TODO::Senthil","instance":"Text_Caption_464","title":"Congratulations.   You selected the correct response.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si42519","class":"TODO::Senthil","instance":"Text_Caption_465","title":"You did not select the correct response.  Please review Dose modification section in the eLearning guide.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si42527","class":"TODO::Senthil","instance":"Text_Caption_466","title":"You must answer the question before continuing ","roles":{"textData":{}}},{"id":"Slide42567","class":"Question Slide","instance":"CLA 1 and 4","thumbnail":"","children":["si15354","si42425","si42440","si42451","si42462","si42473","si42484","si42557","si42527"],"roles":{"slide":{"durationInFrames":90},"navigation":{"navid":"Slide42567"},"question":{"interactionId":"42406","quizId":-1,"title":"Multiple Choice","text":"How would you ensure that a patient’s absolute neutrophil count (ANC) is adequate to proceed with antineoplastic drug administration?\r","type":0,"pool":499,"interactionType":"choice","ramdomized":false,"correctAnswers":["D"],"score":{"weight":0,"penalty":0}}}},{"id":"Text_Caption_485","class":"TODO::Senthil","instance":"Text_Caption_485","title":" eviQ page: Prevention of Chemotherapy Induced Nausea and Vomiting. ","roles":{"textData":{}}},{"id":"si42616","class":"TODO::Senthil","instance":"Text_Caption_468","roles":{}},{"id":"si42628","class":"TODO::Senthil","instance":"Text_Caption_469","title":"Which of the following antineoplastic drugs is classified as having high emetogenicity?  You may need to refer to: ","roles":{"textData":{}}},{"id":"si42639","class":"TODO::Senthil","instance":"Text_Caption_470","title":"A) ","roles":{"textData":{}}},{"id":"si42643","class":"TODO::Senthil","instance":"Text_Caption_471","title":"Gemcitabine ","roles":{"textData":{}}},{"id":"si42639_a","class":"TODO::Senthil","instance":"274","roles":{"answer":{"title":"Gemcitabine\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si42650","class":"TODO::Senthil","instance":"Text_Caption_472","title":"B) ","roles":{"textData":{}}},{"id":"si42654","class":"TODO::Senthil","instance":"Text_Caption_473","title":"Cisplatin ","roles":{"textData":{}}},{"id":"si42650_a","class":"TODO::Senthil","instance":"276","roles":{"answer":{"title":"Cisplatin\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si42661","class":"TODO::Senthil","instance":"Text_Caption_474","title":"C) ","roles":{"textData":{}}},{"id":"si42665","class":"TODO::Senthil","instance":"Text_Caption_475","title":"Etoposide ","roles":{"textData":{}}},{"id":"si42661_a","class":"TODO::Senthil","instance":"278","roles":{"answer":{"title":"Etoposide\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si42672","class":"TODO::Senthil","instance":"Text_Caption_476","title":"D) ","roles":{"textData":{}}},{"id":"si42676","class":"TODO::Senthil","instance":"Text_Caption_477","title":"All of the above ","roles":{"textData":{}}},{"id":"si42672_a","class":"TODO::Senthil","instance":"280","roles":{"answer":{"title":"All of the above\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si42760","class":"TODO::Senthil","instance":"Button_80","title":"Submit ","roles":{"click":{"subtype":"submit","question":"Slide42770q","for":"Slide42770q"},"textData":{}}},{"id":"si42714","class":"TODO::Senthil","instance":"Text_Caption_480","title":"Congratulations.   You selected the correct response.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si42722","class":"TODO::Senthil","instance":"Text_Caption_481","title":"You did not select the correct response.  Please review supportive medications: emetogenicity section in the eLearning guide.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si42730","class":"TODO::Senthil","instance":"Text_Caption_482","title":"You must answer the question before continuing ","roles":{"textData":{}}},{"id":"Slide42770","class":"Question Slide","instance":"CLA 1 and 4","thumbnail":"","children":["si15354","Text_Caption_485","si42628","si42643","si42654","si42665","si42676","si42760","si42730"],"roles":{"slide":{"durationInFrames":90},"navigation":{"navid":"Slide42770"},"question":{"interactionId":"42609","quizId":-1,"title":"Multiple Choice","text":"Which of the following antineoplastic drugs is classified as having high emetogenicity?\r\rYou may need to refer to:\r","type":0,"pool":499,"interactionType":"choice","ramdomized":false,"correctAnswers":["B"],"score":{"weight":0,"penalty":0}}}},{"id":"Text_Caption_513","class":"TODO::Senthil","instance":"Text_Caption_513","title":" eviQ page: Prevention of Chemotherapy Induced Nausea and Vomiting ","roles":{"textData":{}}},{"id":"si43194","class":"TODO::Senthil","instance":"Text_Caption_514","roles":{}},{"id":"si43206","class":"TODO::Senthil","instance":"Text_Caption_515","title":"Which of the following antineoplastic drugs is classified as having low emetogenicity?   You may need to refer to: ","roles":{"textData":{}}},{"id":"si43217","class":"TODO::Senthil","instance":"Text_Caption_516","title":"A) ","roles":{"textData":{}}},{"id":"si43221","class":"TODO::Senthil","instance":"Text_Caption_517","title":"Carboplatin ","roles":{"textData":{}}},{"id":"si43217_a","class":"TODO::Senthil","instance":"302","roles":{"answer":{"title":"Carboplatin\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si43228","class":"TODO::Senthil","instance":"Text_Caption_518","title":"B) ","roles":{"textData":{}}},{"id":"si43232","class":"TODO::Senthil","instance":"Text_Caption_519","title":"Doxorubicin ","roles":{"textData":{}}},{"id":"si43228_a","class":"TODO::Senthil","instance":"304","roles":{"answer":{"title":"Doxorubicin\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si43239","class":"TODO::Senthil","instance":"Text_Caption_520","title":"C) ","roles":{"textData":{}}},{"id":"si43243","class":"TODO::Senthil","instance":"Text_Caption_521","title":"Cisplatin  ","roles":{"textData":{}}},{"id":"si43239_a","class":"TODO::Senthil","instance":"306","roles":{"answer":{"title":"Cisplatin \r","index":"Not implemented","score":{"weight":0}}}},{"id":"si43250","class":"TODO::Senthil","instance":"Text_Caption_522","title":"D) ","roles":{"textData":{}}},{"id":"si43254","class":"TODO::Senthil","instance":"Text_Caption_523","title":"Etoposide ","roles":{"textData":{}}},{"id":"si43250_a","class":"TODO::Senthil","instance":"308","roles":{"answer":{"title":"Etoposide\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si43327","class":"TODO::Senthil","instance":"Button_83","title":"Submit ","roles":{"click":{"subtype":"submit","question":"Slide43337q","for":"Slide43337q"},"textData":{}}},{"id":"si43281","class":"TODO::Senthil","instance":"Text_Caption_524","title":"Congratulations.   You selected the correct response.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si43289","class":"TODO::Senthil","instance":"Text_Caption_525","title":"You did not select the correct response.  Please review supportive medications: emetogenicity section in the eLearning guide.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si43297","class":"TODO::Senthil","instance":"Text_Caption_526","title":"You must answer the question before continuing ","roles":{"textData":{}}},{"id":"Slide43337","class":"Question Slide","instance":"CLA 1 and 4","thumbnail":"","children":["si15354","Text_Caption_513","si43206","si43221","si43232","si43243","si43254","si43327","si43297"],"roles":{"slide":{"durationInFrames":90},"navigation":{"navid":"Slide43337"},"question":{"interactionId":"43175","quizId":-1,"title":"Multiple Choice","text":"Which of the following antineoplastic drugs is classified as having low emetogenicity? \r\rYou may need to refer to:\r","type":0,"pool":499,"interactionType":"choice","ramdomized":false,"correctAnswers":["D"],"score":{"weight":0,"penalty":0}}}},{"id":"si42836","class":"TODO::Senthil","instance":"Text_Caption_484","roles":{}},{"id":"si42848","class":"TODO::Senthil","instance":"Text_Caption_487","title":"To ensure optimal effect, it is recommended that an ORAL antiemetic be  administered ___ minutes prior to antineoplastic drug administration.  ","roles":{"textData":{}}},{"id":"si42859","class":"TODO::Senthil","instance":"Text_Caption_488","title":"A) ","roles":{"textData":{}}},{"id":"si42863","class":"TODO::Senthil","instance":"Text_Caption_489","title":"15 ","roles":{"textData":{}}},{"id":"si42859_a","class":"TODO::Senthil","instance":"284","roles":{"answer":{"title":"15\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si42870","class":"TODO::Senthil","instance":"Text_Caption_490","title":"B) ","roles":{"textData":{}}},{"id":"si42874","class":"TODO::Senthil","instance":"Text_Caption_491","title":"75 ","roles":{"textData":{}}},{"id":"si42870_a","class":"TODO::Senthil","instance":"286","roles":{"answer":{"title":"75\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si42881","class":"TODO::Senthil","instance":"Text_Caption_492","title":"C) ","roles":{"textData":{}}},{"id":"si42885","class":"TODO::Senthil","instance":"Text_Caption_493","title":"90 ","roles":{"textData":{}}},{"id":"si42881_a","class":"TODO::Senthil","instance":"288","roles":{"answer":{"title":"90\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si42892","class":"TODO::Senthil","instance":"Text_Caption_494","title":"D) ","roles":{"textData":{}}},{"id":"si42896","class":"TODO::Senthil","instance":"Text_Caption_495","title":"60 ","roles":{"textData":{}}},{"id":"si42892_a","class":"TODO::Senthil","instance":"290","roles":{"answer":{"title":"60\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si42969","class":"TODO::Senthil","instance":"Button_81","title":"Submit ","roles":{"click":{"subtype":"submit","question":"Slide42979q","for":"Slide42979q"},"textData":{}}},{"id":"si42923","class":"TODO::Senthil","instance":"Text_Caption_496","title":"Congratulations.   You selected the correct response.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si42931","class":"TODO::Senthil","instance":"Text_Caption_497","title":"You did not select the correct response.  Please review supportive medications: emetogenicity section in the eLearning guide.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si42939","class":"TODO::Senthil","instance":"Text_Caption_498","title":"You must answer the question before continuing ","roles":{"textData":{}}},{"id":"Slide42979","class":"Question Slide","instance":"CLA 1 and 4","thumbnail":"","children":["si15354","si42848","si42863","si42874","si42885","si42896","si42969","si42939"],"roles":{"slide":{"durationInFrames":90},"navigation":{"navid":"Slide42979"},"question":{"interactionId":"42817","quizId":-1,"title":"Multiple Choice","text":"To ensure optimal effect, it is recommended that an ORAL antiemetic be \radministered ___ minutes prior to antineoplastic drug administration. \r","type":0,"pool":499,"interactionType":"choice","ramdomized":false,"correctAnswers":["D"],"score":{"weight":0,"penalty":0}}}},{"id":"si44981","class":"TODO::Senthil","instance":"Text_Caption_537","roles":{}},{"id":"si44993","class":"TODO::Senthil","instance":"Text_Caption_538","title":"To ensure optimal effect, it is recommended that an INTRAVENOUS antiemetic be  administered ___ minutes prior to antineoplastic drug administration.  ","roles":{"textData":{}}},{"id":"si45004","class":"TODO::Senthil","instance":"Text_Caption_539","title":"A) ","roles":{"textData":{}}},{"id":"si45008","class":"TODO::Senthil","instance":"Text_Caption_540","title":"15 ","roles":{"textData":{}}},{"id":"si45004_a","class":"TODO::Senthil","instance":"311","roles":{"answer":{"title":"15\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si45015","class":"TODO::Senthil","instance":"Text_Caption_541","title":"B) ","roles":{"textData":{}}},{"id":"si45019","class":"TODO::Senthil","instance":"Text_Caption_542","title":"30 ","roles":{"textData":{}}},{"id":"si45015_a","class":"TODO::Senthil","instance":"313","roles":{"answer":{"title":"30\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si45026","class":"TODO::Senthil","instance":"Text_Caption_543","title":"C) ","roles":{"textData":{}}},{"id":"si45030","class":"TODO::Senthil","instance":"Text_Caption_544","title":"45 ","roles":{"textData":{}}},{"id":"si45026_a","class":"TODO::Senthil","instance":"315","roles":{"answer":{"title":"45\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si45037","class":"TODO::Senthil","instance":"Text_Caption_545","title":"D) ","roles":{"textData":{}}},{"id":"si45041","class":"TODO::Senthil","instance":"Text_Caption_546","title":"60 ","roles":{"textData":{}}},{"id":"si45037_a","class":"TODO::Senthil","instance":"317","roles":{"answer":{"title":"60\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si45114","class":"TODO::Senthil","instance":"Button_85","title":"Submit ","roles":{"click":{"subtype":"submit","question":"Slide45124q","for":"Slide45124q"},"textData":{}}},{"id":"si45068","class":"TODO::Senthil","instance":"Text_Caption_547","title":"Congratulations.   You selected the correct response.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si45076","class":"TODO::Senthil","instance":"Text_Caption_548","title":"You did not select the correct response.  Please review supportive medications: emetogenicity section in the eLearning guide.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si45084","class":"TODO::Senthil","instance":"Text_Caption_549","title":"You must answer the question before continuing ","roles":{"textData":{}}},{"id":"Slide45124","class":"Question Slide","instance":"CLA 1 and 4","thumbnail":"","children":["si15354","si44993","si45008","si45019","si45030","si45041","si45114","si45084"],"roles":{"slide":{"durationInFrames":90},"navigation":{"navid":"Slide45124"},"question":{"interactionId":"44974","quizId":-1,"title":"Multiple Choice","text":"To ensure optimal effect, it is recommended that an INTRAVENOUS antiemetic be \radministered ___ minutes prior to antineoplastic drug administration. \r","type":0,"pool":499,"interactionType":"choice","ramdomized":false,"correctAnswers":["B"],"score":{"weight":0,"penalty":0}}}},{"id":"si41124","class":"TODO::Senthil","instance":"Text_Caption_350","roles":{}},{"id":"si41136","class":"TODO::Senthil","instance":"Text_Caption_351","title":"Clinical trials nurse/coordinators have an important role in: ","roles":{"textData":{}}},{"id":"si41147","class":"TODO::Senthil","instance":"Text_Caption_352","title":"A) ","roles":{"textData":{}}},{"id":"si41151","class":"TODO::Senthil","instance":"Text_Caption_353","title":"Symptom management ","roles":{"textData":{}}},{"id":"si41147_a","class":"TODO::Senthil","instance":"198","roles":{"answer":{"title":"Symptom management\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si41158","class":"TODO::Senthil","instance":"Text_Caption_354","title":"B) ","roles":{"textData":{}}},{"id":"si41162","class":"TODO::Senthil","instance":"Text_Caption_355","title":"Documentation of symptoms and action taken ","roles":{"textData":{}}},{"id":"si41158_a","class":"TODO::Senthil","instance":"200","roles":{"answer":{"title":"Documentation of symptoms and action taken\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si41169","class":"TODO::Senthil","instance":"Text_Caption_356","title":"C) ","roles":{"textData":{}}},{"id":"si41173","class":"TODO::Senthil","instance":"Text_Caption_357","title":"Ensuring protocol compliance ","roles":{"textData":{}}},{"id":"si41169_a","class":"TODO::Senthil","instance":"202","roles":{"answer":{"title":"Ensuring protocol compliance\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si41180","class":"TODO::Senthil","instance":"Text_Caption_358","title":"D) ","roles":{"textData":{}}},{"id":"si41184","class":"TODO::Senthil","instance":"Text_Caption_359","title":"All of the above are correct ","roles":{"textData":{}}},{"id":"si41180_a","class":"TODO::Senthil","instance":"204","roles":{"answer":{"title":"All of the above are correct\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si41268","class":"TODO::Senthil","instance":"Button_72","title":"Submit ","roles":{"click":{"subtype":"submit","question":"Slide41278q","for":"Slide41278q"},"textData":{}}},{"id":"si41222","class":"TODO::Senthil","instance":"Text_Caption_362","title":"Congratulations.   You selected the correct response.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si41230","class":"TODO::Senthil","instance":"Text_Caption_363","title":"You did not select the correct response.  Please review the understanding your role in the clinical trials process section in the eLearning guide.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si41238","class":"TODO::Senthil","instance":"Text_Caption_364","title":"You must answer the question before continuing ","roles":{"textData":{}}},{"id":"Slide41278","class":"Question Slide","instance":"CLA 1 and 4","thumbnail":"","children":["si15354","si41136","si41151","si41162","si41173","si41184","si41268","si41238"],"roles":{"slide":{"durationInFrames":90},"navigation":{"navid":"Slide41278"},"question":{"interactionId":"equiz_module_195915","quizId":-1,"title":"Multiple Choice","text":"Clinical trials nurse/coordinators have an important role in:\r","type":0,"pool":499,"interactionType":"choice","ramdomized":false,"correctAnswers":["D"],"score":{"weight":0,"penalty":0}}}},{"id":"si41481","class":"TODO::Senthil","instance":"Text_Caption_380","roles":{}},{"id":"si41493","class":"TODO::Senthil","instance":"Text_Caption_381","title":"As a nurse administering antineoplastic drugs to a patient enrolled in a clinical trial, you understand a double blinded study to be ","roles":{"textData":{}}},{"id":"si41504","class":"TODO::Senthil","instance":"Text_Caption_382","title":"A) ","roles":{"textData":{}}},{"id":"si41508","class":"TODO::Senthil","instance":"Text_Caption_383","title":"A study where participants are randomly assigned to two or more treatment arms ","roles":{"textData":{}}},{"id":"si41504_a","class":"TODO::Senthil","instance":"217","roles":{"answer":{"title":"A study where participants are randomly assigned to two or more treatment arms\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si41515","class":"TODO::Senthil","instance":"Text_Caption_384","title":"B) ","roles":{"textData":{}}},{"id":"si41519","class":"TODO::Senthil","instance":"Text_Caption_385","title":"A trial to explore ways to improve comfort & quality of life ","roles":{"textData":{}}},{"id":"si41515_a","class":"TODO::Senthil","instance":"219","roles":{"answer":{"title":"A trial to explore ways to improve comfort & quality of life\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si41526","class":"TODO::Senthil","instance":"Text_Caption_386","title":"C) ","roles":{"textData":{}}},{"id":"si41530","class":"TODO::Senthil","instance":"Text_Caption_387","title":"A trial in which neither the participants nor the study staff know who is receiving the trial drug and who is receiving a placebo ","roles":{"textData":{}}},{"id":"si41526_a","class":"TODO::Senthil","instance":"221","roles":{"answer":{"title":"A trial in which neither the participants nor the study staff know who is receiving the trial drug and who is receiving a placebo\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si41537","class":"TODO::Senthil","instance":"Text_Caption_388","title":"D) ","roles":{"textData":{}}},{"id":"si41541","class":"TODO::Senthil","instance":"Text_Caption_389","title":"None of the above are correct ","roles":{"textData":{}}},{"id":"si41537_a","class":"TODO::Senthil","instance":"223","roles":{"answer":{"title":"None of the above are correct\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si41614","class":"TODO::Senthil","instance":"Button_74","title":"Submit ","roles":{"click":{"subtype":"submit","question":"Slide41624q","for":"Slide41624q"},"textData":{}}},{"id":"si41568","class":"TODO::Senthil","instance":"Text_Caption_390","title":"Congratulations.   You selected the correct response.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si41576","class":"TODO::Senthil","instance":"Text_Caption_391","title":"You did not select the correct response.  Please review the understanding your role in the clinical trials process section in the eLearning guide.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si41584","class":"TODO::Senthil","instance":"Text_Caption_392","title":"You must answer the question before continuing ","roles":{"textData":{}}},{"id":"Slide41624","class":"Question Slide","instance":"CLA 1 and 4","thumbnail":"","children":["si15354","si41493","si41508","si41519","si41530","si41541","si41614","si41584"],"roles":{"slide":{"durationInFrames":90},"navigation":{"navid":"Slide41624"},"question":{"interactionId":"41474","quizId":-1,"title":"Multiple Choice","text":"As a nurse administering antineoplastic drugs to a patient enrolled in a clinical trial, you understand a double blinded study to be\r","type":0,"pool":499,"interactionType":"choice","ramdomized":false,"correctAnswers":["C"],"score":{"weight":0,"penalty":0}}}},{"id":"Text_Caption_568","class":"TODO::Senthil","instance":"Text_Caption_568","title":"Link to Small cell lung cancer limited disease - Cisplatin and Etoposide  ","roles":{"textData":{}}},{"id":"si45401","class":"TODO::Senthil","instance":"Text_Caption_569","roles":{}},{"id":"si45413","class":"TODO::Senthil","instance":"Text_Caption_570","title":"Which of the following statement is CORRECT regarding cisplatin being administered for treatment of small cell lung cancer limited disease?   You will need to refer to the eviQ protocol.   ","roles":{"textData":{}}},{"id":"si45424","class":"TODO::Senthil","instance":"Text_Caption_571","title":"A) ","roles":{"textData":{}}},{"id":"si45428","class":"TODO::Senthil","instance":"Text_Caption_572","title":"Cisplatin should not be administered until 500ml of urine has been voided ","roles":{"textData":{}}},{"id":"si45424_a","class":"TODO::Senthil","instance":"329","roles":{"answer":{"title":"Cisplatin should not be administered until 500ml of urine has been voided\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si45435","class":"TODO::Senthil","instance":"Text_Caption_573","title":"B) ","roles":{"textData":{}}},{"id":"si45439","class":"TODO::Senthil","instance":"Text_Caption_574","title":"Hydration helps to prevent cisplatin induced nephrotoxicity ","roles":{"textData":{}}},{"id":"si45435_a","class":"TODO::Senthil","instance":"331","roles":{"answer":{"title":"Hydration helps to prevent cisplatin induced nephrotoxicity\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si45446","class":"TODO::Senthil","instance":"Text_Caption_575","title":"C) ","roles":{"textData":{}}},{"id":"si45450","class":"TODO::Senthil","instance":"Text_Caption_576","title":"Cisplatin is not associated with nephrotoxicity ","roles":{"textData":{}}},{"id":"si45446_a","class":"TODO::Senthil","instance":"333","roles":{"answer":{"title":"Cisplatin is not associated with nephrotoxicity\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si45457","class":"TODO::Senthil","instance":"Text_Caption_577","title":"D) ","roles":{"textData":{}}},{"id":"si45461","class":"TODO::Senthil","instance":"Text_Caption_578","title":"Both A and B are correct ","roles":{"textData":{}}},{"id":"si45457_a","class":"TODO::Senthil","instance":"335","roles":{"answer":{"title":"Both A and B are correct\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si45468","class":"TODO::Senthil","instance":"Text_Caption_579","title":"E) ","roles":{"textData":{}}},{"id":"si45472","class":"TODO::Senthil","instance":"Text_Caption_580","title":"Both A and C are correct ","roles":{"textData":{}}},{"id":"si45468_a","class":"TODO::Senthil","instance":"337","roles":{"answer":{"title":"Both A and C are correct\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si45545","class":"TODO::Senthil","instance":"Button_87","title":"Submit ","roles":{"click":{"subtype":"submit","question":"Slide45555q","for":"Slide45555q"},"textData":{}}},{"id":"si45499","class":"TODO::Senthil","instance":"Text_Caption_581","title":"Congratulations.   You selected the correct response.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si45507","class":"TODO::Senthil","instance":"Text_Caption_582","title":"You did not select the correct response.  Please review supportive medication to prevent nephrotoxicitysection in the eLearning guide.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si45515","class":"TODO::Senthil","instance":"Text_Caption_583","title":"You must answer the question before continuing ","roles":{"textData":{}}},{"id":"Slide45555","class":"Question Slide","instance":"protocol","thumbnail":"","children":["si15354","Text_Caption_568","si45413","si45428","si45439","si45450","si45461","si45472","si45545","si45515"],"roles":{"slide":{"durationInFrames":90},"navigation":{"navid":"Slide45555"},"question":{"interactionId":"45382","quizId":-1,"title":"Multiple Choice","text":"Which of the following statement is CORRECT regarding cisplatin being administered for treatment of small cell lung cancer limited disease? \r\rYou will need to refer to the eviQ protocol. \r\r","type":0,"pool":499,"interactionType":"choice","ramdomized":false,"correctAnswers":["B"],"score":{"weight":0,"penalty":0}}}},{"id":"Text_Caption_552","class":"TODO::Senthil","instance":"Text_Caption_552","title":"Link to Small cell lung cancer limited disease - Cisplatin and Etoposide  ","roles":{"textData":{}}},{"id":"si38334","class":"TODO::Senthil","instance":"Text_Caption_130","roles":{}},{"id":"si38346","class":"TODO::Senthil","instance":"Text_Caption_131","title":"A patient is being administered treatment for small cell lung cancer limited disease. Prior to administering cisplatin, it is important that the patient:   You will need to refer to the eviQ protocol ","roles":{"textData":{}}},{"id":"si38357","class":"TODO::Senthil","instance":"Text_Caption_132","title":"A) ","roles":{"textData":{}}},{"id":"si38361","class":"TODO::Senthil","instance":"Text_Caption_133","title":"Receives adequate information about the side effect of haemorrhagic cystitis ","roles":{"textData":{}}},{"id":"si38357_a","class":"TODO::Senthil","instance":"56","roles":{"answer":{"title":"Receives adequate information about the side effect of haemorrhagic cystitis\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si38368","class":"TODO::Senthil","instance":"Text_Caption_134","title":"B) ","roles":{"textData":{}}},{"id":"si38372","class":"TODO::Senthil","instance":"Text_Caption_135","title":"Eats a meal ","roles":{"textData":{}}},{"id":"si38368_a","class":"TODO::Senthil","instance":"58","roles":{"answer":{"title":"Eats a meal\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si38382","class":"TODO::Senthil","instance":"Text_Caption_136","title":"C) ","roles":{"textData":{}}},{"id":"si38386","class":"TODO::Senthil","instance":"Text_Caption_137","title":"Receives pre hydration as recommended in the treatment protocol ","roles":{"textData":{}}},{"id":"si38382_a","class":"TODO::Senthil","instance":"60","roles":{"answer":{"title":"Receives pre hydration as recommended in the treatment protocol\r","index":"Not implemented","score":{"weight":10}}}},{"id":"si38393","class":"TODO::Senthil","instance":"Text_Caption_138","title":"D) ","roles":{"textData":{}}},{"id":"si38397","class":"TODO::Senthil","instance":"Text_Caption_139","title":"Drinks a lot of fluid ","roles":{"textData":{}}},{"id":"si38393_a","class":"TODO::Senthil","instance":"62","roles":{"answer":{"title":"Drinks a lot of fluid\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si38470","class":"TODO::Senthil","instance":"Button_10","title":"Submit ","roles":{"click":{"subtype":"submit","question":"Slide38480q","for":"Slide38480q"},"textData":{}}},{"id":"si38424","class":"TODO::Senthil","instance":"Text_Caption_140","title":"Congratulations.   You selected the correct response.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si38432","class":"TODO::Senthil","instance":"Text_Caption_141","title":"You did not select the correct response.  Please review the supportive medication to prevent nephrotoxicity section in the eLearning guide.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si38440","class":"TODO::Senthil","instance":"Text_Caption_142","title":"You must answer the question before continuing ","roles":{"textData":{}}},{"id":"Slide38480","class":"Question Slide","instance":"protocol","thumbnail":"","children":["si15354","Text_Caption_552","si38346","si38361","si38372","si38386","si38397","si38470","si38440"],"roles":{"slide":{"durationInFrames":90},"navigation":{"navid":"Slide38480"},"question":{"interactionId":"38327","quizId":-1,"title":"Multiple Choice","text":"A patient is being administered treatment for small cell lung cancer limited disease. Prior to administering cisplatin, it is important that the patient: \r\rYou will need to refer to the eviQ protocol\r","type":0,"pool":499,"interactionType":"choice","ramdomized":false,"correctAnswers":["C"],"score":{"weight":10,"penalty":0}}}},{"id":"Text_Caption_553","class":"TODO::Senthil","instance":"Text_Caption_553","title":"Link to Small cell lung cancer limited disease - Cisplatin and Etoposide  ","roles":{"textData":{}}},{"id":"si45209","class":"TODO::Senthil","instance":"Text_Caption_554","roles":{}},{"id":"si45221","class":"TODO::Senthil","instance":"Text_Caption_555","title":"A patient is being administered treatment for small cell lung cancer limited disease. Which of the following is a possible side effect of cisplatin and etoposide administration?  You will need to refer to the eviQ protocol ","roles":{"textData":{}}},{"id":"si45232","class":"TODO::Senthil","instance":"Text_Caption_556","title":"A) ","roles":{"textData":{}}},{"id":"si45236","class":"TODO::Senthil","instance":"Text_Caption_557","title":"Hand and foot syndrome ","roles":{"textData":{}}},{"id":"si45232_a","class":"TODO::Senthil","instance":"320","roles":{"answer":{"title":"Hand and foot syndrome\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si45243","class":"TODO::Senthil","instance":"Text_Caption_558","title":"B) ","roles":{"textData":{}}},{"id":"si45247","class":"TODO::Senthil","instance":"Text_Caption_559","title":"Diarrhoea ","roles":{"textData":{}}},{"id":"si45243_a","class":"TODO::Senthil","instance":"322","roles":{"answer":{"title":"Diarrhoea\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si45257","class":"TODO::Senthil","instance":"Text_Caption_560","title":"C) ","roles":{"textData":{}}},{"id":"si45261","class":"TODO::Senthil","instance":"Text_Caption_561","title":"Hypersensitivity ","roles":{"textData":{}}},{"id":"si45257_a","class":"TODO::Senthil","instance":"324","roles":{"answer":{"title":"Hypersensitivity\r","index":"Not implemented","score":{"weight":10}}}},{"id":"si45268","class":"TODO::Senthil","instance":"Text_Caption_562","title":"D) ","roles":{"textData":{}}},{"id":"si45272","class":"TODO::Senthil","instance":"Text_Caption_563","title":"Haemorrhagic cystitis ","roles":{"textData":{}}},{"id":"si45268_a","class":"TODO::Senthil","instance":"326","roles":{"answer":{"title":"Haemorrhagic cystitis\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si45345","class":"TODO::Senthil","instance":"Button_86","title":"Submit ","roles":{"click":{"subtype":"submit","question":"Slide45355q","for":"Slide45355q"},"textData":{}}},{"id":"si45299","class":"TODO::Senthil","instance":"Text_Caption_564","title":"Congratulations.   You selected the correct response.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si45307","class":"TODO::Senthil","instance":"Text_Caption_565","title":"You did not select the correct response.  Please review the dose modification section in the eLearning guide.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si45315","class":"TODO::Senthil","instance":"Text_Caption_566","title":"You must answer the question before continuing ","roles":{"textData":{}}},{"id":"Slide45355","class":"Question Slide","instance":"protocol","thumbnail":"","children":["si15354","Text_Caption_553","si45221","si45236","si45247","si45261","si45272","si45345","si45315"],"roles":{"slide":{"durationInFrames":90},"navigation":{"navid":"Slide45355"},"question":{"interactionId":"45190","quizId":-1,"title":"Multiple Choice","text":"A patient is being administered treatment for small cell lung cancer limited disease. Which of the following is a possible side effect of cisplatin and etoposide administration?\r\rYou will need to refer to the eviQ protocol\r","type":0,"pool":499,"interactionType":"choice","ramdomized":false,"correctAnswers":["C"],"score":{"weight":10,"penalty":0}}}},{"id":"Text_Caption_551","class":"TODO::Senthil","instance":"Text_Caption_551","title":"Link to non-Hodgkin Lymphoma - ICE  ","roles":{"textData":{}}},{"id":"si42206","class":"TODO::Senthil","instance":"Text_Caption_438","roles":{}},{"id":"si42218","class":"TODO::Senthil","instance":"Text_Caption_439","title":"Which of the following statements are CORRECT regarding administration of ifosfamide for treatment of non-Hodgkin Lymphoma? Note: More than one answer may be correct.  You will need to refer to eviQ protocol using the link below.  ","roles":{"textData":{}}},{"id":"si42229","class":"TODO::Senthil","instance":"Text_Caption_440","title":"A) ","roles":{"textData":{}}},{"id":"si42233","class":"TODO::Senthil","instance":"Text_Caption_441","title":"Urine output for patients receiving ifosfamide should be maintained at 100 mL/hr  ","roles":{"textData":{}}},{"id":"si42233","class":"TODO::Senthil","roles":{"click":{"subtype":"button","question":"Slide42349q"},"answer":{"title":"dummy title","index":-1,"score":{}}}},{"id":"si42229_a","class":"TODO::Senthil","roles":{"answer":{"title":"Urine output for patients receiving ifosfamide should be maintained at 100 mL/hr \r","index":"Not implemented","score":{"weight":0}}}},{"id":"si42240","class":"TODO::Senthil","instance":"Text_Caption_442","title":"B) ","roles":{"textData":{}}},{"id":"si42244","class":"TODO::Senthil","instance":"Text_Caption_443","title":"Ifosfamide may result in haemorrhagic cystitis if adequate attention is not paid to hydration ","roles":{"textData":{}}},{"id":"si42244","class":"TODO::Senthil","roles":{"click":{"subtype":"button","question":"Slide42349q"},"answer":{"title":"dummy title","index":-1,"score":{}}}},{"id":"si42240_a","class":"TODO::Senthil","roles":{"answer":{"title":"Ifosfamide may result in haemorrhagic cystitis if adequate attention is not paid to hydration\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si42251","class":"TODO::Senthil","instance":"Text_Caption_444","title":"C) ","roles":{"textData":{}}},{"id":"si42255","class":"TODO::Senthil","instance":"Text_Caption_445","title":"Ifosfamide is not associated with haemorrhagic cystitis ","roles":{"textData":{}}},{"id":"si42255","class":"TODO::Senthil","roles":{"click":{"subtype":"button","question":"Slide42349q"},"answer":{"title":"dummy title","index":-1,"score":{}}}},{"id":"si42251_a","class":"TODO::Senthil","roles":{"answer":{"title":"Ifosfamide is not associated with haemorrhagic cystitis\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si42262","class":"TODO::Senthil","instance":"Text_Caption_446","title":"D) ","roles":{"textData":{}}},{"id":"si42266","class":"TODO::Senthil","instance":"Text_Caption_447","title":"The patient should receive appropriate information about the side effect haemorrhagic cystitis ","roles":{"textData":{}}},{"id":"si42266","class":"TODO::Senthil","roles":{"click":{"subtype":"button","question":"Slide42349q"},"answer":{"title":"dummy title","index":-1,"score":{}}}},{"id":"si42262_a","class":"TODO::Senthil","roles":{"answer":{"title":"The patient should receive appropriate information about the side effect haemorrhagic cystitis\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si42357","class":"TODO::Senthil","title":"E) ","roles":{"textData":{}}},{"id":"si42361","class":"TODO::Senthil","title":"Receiving hyper hydration is effective in diluting the concentration of acrolein and reducing bladder toxicity ","roles":{"textData":{}}},{"id":"si42361","class":"TODO::Senthil","roles":{"click":{"subtype":"button","question":"Slide42349q"},"answer":{"title":"dummy title","index":-1,"score":{}}}},{"id":"si42357_a","class":"TODO::Senthil","roles":{"answer":{"title":"Receiving hyper hydration is effective in diluting the concentration of acrolein and reducing bladder toxicity\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si42339","class":"TODO::Senthil","instance":"Button_78","title":"Submit ","roles":{"click":{"subtype":"submit","question":"Slide42349q","for":"Slide42349q"},"textData":{}}},{"id":"si42293","class":"TODO::Senthil","instance":"Text_Caption_448","title":"Congratulations.   You selected the correct response.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si42301","class":"TODO::Senthil","instance":"Text_Caption_449","title":"You did not select the correct response.  Please review supportive medication to prevent nephrotoxicity section in the eLearning guide.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si42309","class":"TODO::Senthil","instance":"Text_Caption_450","title":"You must answer the question before continuing ","roles":{"textData":{}}},{"id":"Slide42349","class":"Question Slide","instance":"protocol","thumbnail":"","children":["si15354","Text_Caption_551","si42218","si42233","si42244","si42255","si42266","si42361","si42339","si42309"],"roles":{"slide":{"durationInFrames":90},"navigation":{"navid":"Slide42349"},"question":{"interactionId":"50299","quizId":-1,"title":"Multiple Choice","text":"Which of the following statements are CORRECT regarding administration of ifosfamide for treatment of non-Hodgkin Lymphoma? Note: More than one answer may be correct.\r\rYou will need to refer to eviQ protocol using the link below.\r\r","type":0,"pool":499,"interactionType":"choice","ramdomized":false,"correctAnswers":["B","D","E"],"score":{"weight":0,"penalty":0}}}},{"id":"Text_Caption_585","class":"TODO::Senthil","instance":"Text_Caption_585","title":"Link to non-Hodgkin Lymphoma - ICE  ","roles":{"textData":{}}},{"id":"si45616","class":"TODO::Senthil","instance":"Text_Caption_586","roles":{}},{"id":"si45628","class":"TODO::Senthil","instance":"Text_Caption_587","title":"Which of the following is a possible side effect of ifosfamide, carboplatin and etoposide (ICE) administration?   You will need to refer to the eviQ protocol ","roles":{"textData":{}}},{"id":"si45639","class":"TODO::Senthil","instance":"Text_Caption_588","title":"A) ","roles":{"textData":{}}},{"id":"si45643","class":"TODO::Senthil","instance":"Text_Caption_589","title":"Hand and foot syndrome ","roles":{"textData":{}}},{"id":"si45639_a","class":"TODO::Senthil","instance":"340","roles":{"answer":{"title":"Hand and foot syndrome\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si45650","class":"TODO::Senthil","instance":"Text_Caption_590","title":"B) ","roles":{"textData":{}}},{"id":"si45654","class":"TODO::Senthil","instance":"Text_Caption_591","title":"Peripheral neuropathy ","roles":{"textData":{}}},{"id":"si45650_a","class":"TODO::Senthil","instance":"342","roles":{"answer":{"title":"Peripheral neuropathy\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si45664","class":"TODO::Senthil","instance":"Text_Caption_592","title":"C) ","roles":{"textData":{}}},{"id":"si45668","class":"TODO::Senthil","instance":"Text_Caption_593","title":"Hypersensitivity ","roles":{"textData":{}}},{"id":"si45664_a","class":"TODO::Senthil","instance":"344","roles":{"answer":{"title":"Hypersensitivity\r","index":"Not implemented","score":{"weight":10}}}},{"id":"si45675","class":"TODO::Senthil","instance":"Text_Caption_594","title":"D) ","roles":{"textData":{}}},{"id":"si45679","class":"TODO::Senthil","instance":"Text_Caption_595","title":"Cardiotoxicity ","roles":{"textData":{}}},{"id":"si45675_a","class":"TODO::Senthil","instance":"346","roles":{"answer":{"title":"Cardiotoxicity\r","index":"Not implemented","score":{"weight":0}}}},{"id":"si45752","class":"TODO::Senthil","instance":"Button_88","title":"Submit ","roles":{"click":{"subtype":"submit","question":"Slide45762q","for":"Slide45762q"},"textData":{}}},{"id":"si45706","class":"TODO::Senthil","instance":"Text_Caption_596","title":"Congratulations.   You selected the correct response.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si45714","class":"TODO::Senthil","instance":"Text_Caption_597","title":"You did not select the correct response.  Please review the dose modification section in the eLearning guide.  Click anywhere on the screen to continue. ","roles":{"textData":{}}},{"id":"si45722","class":"TODO::Senthil","instance":"Text_Caption_598","title":"You must answer the question before continuing ","roles":{"textData":{}}},{"id":"Slide45762","class":"Question Slide","instance":"protocol","thumbnail":"","children":["si15354","Text_Caption_585","si45628","si45643","si45654","si45668","si45679","si45752","si45722"],"roles":{"slide":{"durationInFrames":90},"navigation":{"navid":"Slide45762"},"question":{"interactionId":"45597","quizId":-1,"title":"Multiple Choice","text":"Which of the following is a possible side effect of ifosfamide, carboplatin and etoposide (ICE) administration? \r\rYou will need to refer to the eviQ protocol\r","type":0,"pool":499,"interactionType":"choice","ramdomized":false,"correctAnswers":["C"],"score":{"weight":10,"penalty":0}}}},{"id":"eQuiz3","class":"project","title":"eQuiz3","children":["Slide3935","Slide43532","Slide44027","Slide44048","Slide44069","Slide44237","Slide44111","Slide44132","Slide44368","Slide44469","Slide44570","Slide44216","Slide17954"],"roles":{"quiz":{"id":455,"branched":false,"submitAll":false,"review":true,"questions":["rqSlide44027","rqSlide44048","rqSlide44069","Slide44237q3","rqSlide44111","rqSlide44132","Slide44368q6","Slide44469q7","Slide44570q8","rqSlide44216"],"minScore":0,"maxScore":10,"passScore":10}}}],"contentSettings":{"global":{"branchAware":false},"toc":{"enabled":false},"playbar":{"enabled":false}},"contentReporting":{"CCCriteria":"quiz","CCData":{"quizData":"quiz_passed"},"SCCriteria":"quiz","SCData":{"quizData":"quiz_passed"},"exitNormalIfCompleted":true},"toc":[{"id":"Slide3935","title":"Welcome"},{"id":"Slide43532","title":"Slide 2"},{"id":"Slide44027","title":"Slide 3"},{"id":"Slide44048","title":"Slide 4"},{"id":"Slide44069","title":"Slide 5"},{"id":"Slide44237","title":"Slide 6"},{"id":"Slide44111","title":"Slide 7"},{"id":"Slide44132","title":"Slide 8"},{"id":"Slide44368","title":"Slide 9"},{"id":"Slide44469","title":"Slide 10"},{"id":"Slide44570","title":"Slide 11"},{"id":"Slide44216","title":"Slide 12"},{"id":"Slide17954","title":"Slide 13"}]}